A point mutation in PTPRC is associated with the development of multiple sclerosis-Reference-Cited by-同舟云学术

A point mutation in PTPRC is associated with the development of multiple sclerosis

Published:2000-12 Issue:4 Volume:26 Page:495-499
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Jacobsen Marc,Schweer Dorothee,Ziegler Andreas,Gaber Rami,Schock Sabine,Schwinzer Reinhard,Wonigeit Kurt,Lindert Ralf-Björn,Kantarci Orhun,Schaefer-Klein Janet,Schipper Hayo I.,Oertel Wolfgang H.,Heidenreich Fedor,Weinshenker Brian G.,Sommer Norbert,Hemmer Bernhard

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng1200_495.pdf

Reference26 articles.

1. Martin, R., McFarland, H.F. & McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153–187 (1992).

2. Hafler, D.A. & Weiner, H.L. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144, 75–107 (1995).

3. Steinman, L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299–302 (1996).

4. Noseworthy, J.H. Progress in determining the causes and treatment of multiple sclerosis. Nature 399, 40–47 (1999).

5. Sawcer, S., Goodfellow, P.N. & Compston, A. The genetic analysis of multiple sclerosis. Trends Genet. 13, 234–239 (1997).

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular signaling towards T cell immunological self-tolerance;Journal of Biological Chemistry;2024-04

2. A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility;Genes;2022-12-16

3. Defining Molecular Treatment Targets for Bladder Pain Syndrome/Interstitial Cystitis: Uncovering Adhesion Molecules;Frontiers in Pharmacology;2022-03-25

4. Burden of rare coding variants in an Italian cohort of familial multiple sclerosis;Journal of Neuroimmunology;2022-01

5. Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery;Medicinal Research Reviews;2021-11-17